ATE25980T1 - Substituierte 9-(1-0- oder 3-0-monosubstituierte oder 1,3-di-0-substituierte 1,3-dihydroxy-2propoxymethyl)-purine als antivirale wirkstoffe. - Google Patents

Substituierte 9-(1-0- oder 3-0-monosubstituierte oder 1,3-di-0-substituierte 1,3-dihydroxy-2propoxymethyl)-purine als antivirale wirkstoffe.

Info

Publication number
ATE25980T1
ATE25980T1 AT83107818T AT83107818T ATE25980T1 AT E25980 T1 ATE25980 T1 AT E25980T1 AT 83107818 T AT83107818 T AT 83107818T AT 83107818 T AT83107818 T AT 83107818T AT E25980 T1 ATE25980 T1 AT E25980T1
Authority
AT
Austria
Prior art keywords
sup
carbon atoms
hydrogen
substituted
antiviral agents
Prior art date
Application number
AT83107818T
Other languages
English (en)
Inventor
Julien Pierre Henri Verheyden
John Charles Martin
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Application granted granted Critical
Publication of ATE25980T1 publication Critical patent/ATE25980T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C07C43/1745—Unsaturated ethers containing halogen containing six-membered aromatic rings having more than one ether bound
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1785—Unsaturated ethers containing hydroxy or O-metal groups having more than one ether bound
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT83107818T 1982-08-09 1983-08-08 Substituierte 9-(1-0- oder 3-0-monosubstituierte oder 1,3-di-0-substituierte 1,3-dihydroxy-2propoxymethyl)-purine als antivirale wirkstoffe. ATE25980T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/406,583 US4556659A (en) 1982-08-09 1982-08-09 Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents
EP83107818A EP0105135B1 (de) 1982-08-09 1983-08-08 Substituierte 9-(1-0- oder 3-0-monosubstituierte oder 1,3-di-0-substituierte 1,3-Dihydroxy-2-propoxymethyl)-purine als antivirale Wirkstoffe

Publications (1)

Publication Number Publication Date
ATE25980T1 true ATE25980T1 (de) 1987-04-15

Family

ID=23608623

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83107818T ATE25980T1 (de) 1982-08-09 1983-08-08 Substituierte 9-(1-0- oder 3-0-monosubstituierte oder 1,3-di-0-substituierte 1,3-dihydroxy-2propoxymethyl)-purine als antivirale wirkstoffe.

Country Status (15)

Country Link
US (1) US4556659A (de)
EP (1) EP0105135B1 (de)
JP (1) JPS5948483A (de)
KR (1) KR890000811B1 (de)
AT (1) ATE25980T1 (de)
AU (1) AU571451B2 (de)
DE (1) DE3370331D1 (de)
DK (1) DK361383A (de)
ES (2) ES524811A0 (de)
FI (1) FI74006C (de)
HU (1) HU193530B (de)
IE (1) IE55843B1 (de)
NO (1) NO162469C (de)
NZ (1) NZ205171A (de)
ZA (1) ZA835799B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816447A (en) * 1981-08-26 1989-03-28 Merck & Co., Inc. Anti-viral guanine compounds
US4609661A (en) * 1982-08-09 1986-09-02 Syntex (U.S.A.) Inc. Substituted 9-(1-O- or 3-O-monosubstituted or 1,3-di-O-substituted propoxymethyl)purines as antiviral agents
ATE33653T1 (de) * 1982-10-14 1988-05-15 Wellcome Found Antivirale purinderivate.
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
US4897479A (en) * 1983-09-30 1990-01-30 Merck & Co., Inc. Arylsulfonyloxy purine intermediates
SE8406538D0 (sv) * 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
US4642346A (en) * 1985-06-24 1987-02-10 Syntex (U.S.A.) Inc. Anhydrous crystalline 9-(1,3-dihydroxy-2-propoxymethyl)guanine
GB8904855D0 (en) * 1989-03-03 1989-04-12 Beecham Group Plc Pharmaceutical treatment
DE4002792A1 (de) * 1990-01-31 1991-08-01 Teves Gmbh Alfred Vorrichtung zur ermittlung der beschaffenheit einer druckuebertragungsfluessigkeit
GB2260319B (en) 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
CN110026212B (zh) * 2019-05-23 2022-03-04 临海市利民化工有限公司 一种裂解催化剂及使用该催化剂制备西他沙星中间体的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
AT380252B (de) * 1981-08-11 1986-05-12 Wellcome Found Verfahren zur herstellung von neuen guanin- und 2,6-diaminopurinderivaten und ihren salzen
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation

Also Published As

Publication number Publication date
DE3370331D1 (en) 1987-04-23
AU1768383A (en) 1984-02-16
ES8603185A1 (es) 1986-01-01
NZ205171A (en) 1987-05-29
FI74006B (fi) 1987-08-31
EP0105135A1 (de) 1984-04-11
KR840006007A (ko) 1984-11-21
EP0105135B1 (de) 1987-03-18
ES545261A0 (es) 1986-01-01
HU193530B (en) 1987-10-28
NO832842L (no) 1984-02-10
KR890000811B1 (ko) 1989-04-08
JPS5948483A (ja) 1984-03-19
AU571451B2 (en) 1988-04-21
FI832832A (fi) 1984-02-10
DK361383D0 (da) 1983-08-08
ZA835799B (en) 1984-04-25
FI74006C (fi) 1987-12-10
NO162469B (no) 1989-09-25
FI832832A0 (fi) 1983-08-08
DK361383A (da) 1984-02-10
IE831867L (en) 1984-02-09
ES524811A0 (es) 1986-01-01
NO162469C (no) 1990-01-10
IE55843B1 (en) 1991-01-30
US4556659A (en) 1985-12-03
ES8603186A1 (es) 1986-01-01

Similar Documents

Publication Publication Date Title
ES8504194A1 (es) Procedimiento para preparar 9-(1 o 3-monoaciloxi-o 1,3-diaciloxi-2-propoximetil)-purinas substituidas en calidad de agentes antiviricos.
ATE25980T1 (de) Substituierte 9-(1-0- oder 3-0-monosubstituierte oder 1,3-di-0-substituierte 1,3-dihydroxy-2propoxymethyl)-purine als antivirale wirkstoffe.
ES8203388A1 (es) Un procedimiento para la preparacion de nuevos derivados de imidazo-rifamicina
GB1040545A (en) Improvements in or relating to therapeutic compounds and the manufacture thereof
ES2081308T3 (es) Nucleosidos fosfolipidos.
ES2058670T3 (es) Derivados amidicos y preparados dermatologicos que los contienen.
ES451602A1 (es) Un procedimiento para la preparacion de una composicion de- tergente liquida.
ES2087275T3 (es) Procedimiento de molturacion de dispersion de quinacridonas.
ES451235A1 (es) Un procedimiento para la preparacion de una composicion de- tergente.
ES8506979A1 (es) Procedimiento para preparar nuevas sales de alquil (cadena larga) amonio de n-fosfonometilglicina
BR8500851A (pt) Processo para produzir um derivado de benzoilureia e processo para produzir uma composicao inseticida e/ou ovicida
ATE50773T1 (de) Alkylresorcinolphosphite.
ES8306378A1 (es) "un procedimiento para la preparacion de derivados de adenosina".
ES8203916A1 (es) Procedimiento para preparar n6-adenosina
MX11083A (es) Sulfonildecahidro-8h-isoquino[2,1-g][1,6] naftiridinas, isomeros opticos de las mismas y compuestos relacionados
KR860700203A (ko) 금속 도금전에 플라스틱 기판의 표면을 상태조절하기 위한 조성물 및 그 방법
ES8301931A1 (es) Un procedimiento para la preparacion de nuevos imidazoles.
ES8203917A1 (es) Un procedimiento para la preparacion de un derivado de nu- cleosido de adenina
EP0044266A3 (en) Substituted 3,5-diamino-1,2,4-oxadiazoles and 3,5-diamino-1,2,4-thiadiazoles, their preparation and use
DE2963942D1 (en) N-(1,2-azolyl)alkyl-chloroacetanilides, process for their preparation and their use as herbicides
PE42998A1 (es) Derivados 1,25-dihidroxi-16,22,23-tridehidro-colecalciferol
GB1457245A (en) Cyclohexenyl compounds
TH3207EX (th) อนุพันธ์ของกรดเฟนนอกซีโปรบีโอนิค
IL60893A0 (en) S-alkyl phosphonodithioic halides and their preparation
ES2056721B1 (es) Mejoras en el objeto de la patente de invencion n{ 9101355 que se refiere a procedimiento de obtencion de nuevos derivados de platino con aminopirrolidinas.